- Recent Funding
- Investors
- The Leukemia & Lymphoma Society’s Therapy Acceleration Program
T
The Leukemia & Lymphoma Society’s Therapy Acceleration Program portfolio
The Leukemia & Lymphoma Society’s Therapy Acceleration Program has 1 portfolio company on record at Recent Funding.
About this page
That company is in Health and bio.
What The Leukemia & Lymphoma Society’s Therapy Acceleration Program invests in
- Health and bio · 1 · 100%
The Leukemia & Lymphoma Society’s Therapy Acceleration Program portfolio companies
RRgenta Therapeuticsbacker
| Company | Round with The Leukemia & Lymphoma Society’s Therapy Acceleration Program | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
backer | $52M | Nov 3, 2026 Series B+ |
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Portfolio companies are the companies on Recent Funding with a round that lists The Leukemia & Lymphoma Society’s Therapy Acceleration Program, which is a subset of its real portfolio. API: /api/v1/investors/the-leukemia-lymphoma-society-s-therapy-acceleration-program (get a free API key). More: the most active VC firms and new venture capital funds.